231 related articles for article (PubMed ID: 15643282)
21. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis.
Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N
Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529
[TBL] [Abstract][Full Text] [Related]
22. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
Abu-Amarah I; Balment RJ
Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
[TBL] [Abstract][Full Text] [Related]
23. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.
Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252
[TBL] [Abstract][Full Text] [Related]
24. EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy.
Reyes AA; Martin D; Settle S; Klahr S
Kidney Int; 1992 Feb; 41(2):403-13. PubMed ID: 1552713
[TBL] [Abstract][Full Text] [Related]
25. A renorenal suppression in response to atrial natriuretic peptide in the unilateral ischaemic rat.
Torikai S
Clin Sci (Lond); 1988 May; 74(5):519-25. PubMed ID: 2967139
[TBL] [Abstract][Full Text] [Related]
26. The pathogenesis of post-obstructive diuresis. The role of circulating natriuretic and diuretic factors, including urea.
Harris RH; Yarger WE
J Clin Invest; 1975 Oct; 56(4):880-7. PubMed ID: 1159091
[TBL] [Abstract][Full Text] [Related]
27. Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP.
Boric MP; Bravo JA; Corbalan M; Vergara C; Roblero JS
Biol Res; 1998; 31(3):281-9. PubMed ID: 9830516
[TBL] [Abstract][Full Text] [Related]
28. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
29. Relationship between renal mass and atrial natriuretic peptide release. 2. Acute effects of various degrees of renal damage on atrial natriuretic peptide release in rats.
Averbukh Z; Berman S; Weissgarten J; Cohn M; Golik A; Cohen N; Modai D
Ren Physiol Biochem; 1994; 17(2):108-12. PubMed ID: 7513898
[TBL] [Abstract][Full Text] [Related]
30. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats.
Ura N; Shimamoto K; Kuroda S; Nomura N; Iwata M; Aoyama T; Iimura O
Clin Exp Hypertens; 1994 Nov; 16(6):799-808. PubMed ID: 7858560
[TBL] [Abstract][Full Text] [Related]
31. Chlorotyrosine exerts renal effects and antagonizes renal and gastric responses to atrial natriuretic peptide.
Chen QM; Smyth DD; McKenzie JK; Glavin GB; Gu JG; Geiger JD; LaBella FS
J Pharmacol Exp Ther; 1994 May; 269(2):709-16. PubMed ID: 7910211
[TBL] [Abstract][Full Text] [Related]
32. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
33. Intrarenal hemodynamics and ureteral pressure during ureteral obstruction.
Hsu CH; Kurtz TW; Rosenzweig J; Weller JM
Invest Urol; 1977 May; 14(6):442-5. PubMed ID: 870444
[TBL] [Abstract][Full Text] [Related]
34. [Activity and localization of neutral metalloendopeptidase (EC 3.4.24.11) (NEP), the degradative enzyme for atrial natriuretic peptide (ANP), in rat kidney].
Kanazawa M; Yasujima M; Kohzuki M; Abe K
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):791-9. PubMed ID: 8072216
[TBL] [Abstract][Full Text] [Related]
35. Renal function after release of ureteral obstruction: role of endothelin and the renal artery endothelium.
Reyes AA; Klahr S
Kidney Int; 1992 Sep; 42(3):632-8. PubMed ID: 1405341
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
Shimizu MH; Danilovic A; Andrade L; Volpini RA; Libório AB; Sanches TR; Seguro AC
Nephrol Dial Transplant; 2008 Oct; 23(10):3067-73. PubMed ID: 18469310
[TBL] [Abstract][Full Text] [Related]
37. [Atrial natriuretic peptide in children with nephrotic syndrome].
Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
[TBL] [Abstract][Full Text] [Related]
38. [Atrium natriuretic peptide in kidney diseases].
Jovanović O
Srp Arh Celok Lek; 1993; 121(3-7):89-91. PubMed ID: 7716646
[TBL] [Abstract][Full Text] [Related]
39. Modification of the renal response to endopeptidase inhibition and atrial natriuretic peptide infusion in normal dogs.
Levy M; Cernacek P
Can J Physiol Pharmacol; 1992 Dec; 70(12):1563-70. PubMed ID: 1301233
[TBL] [Abstract][Full Text] [Related]
40. Factors inducing post-obstructive diuresis in rats.
Sophasan S; Sorrasuchart S
Nephron; 1984; 38(2):125-33. PubMed ID: 6472540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
